Shanghai Hutchison Pharmaceuticals Limited
Clinical trials sponsored by Shanghai Hutchison Pharmaceuticals Limited, explained in plain language.
-
New stroke drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested a new medicine called SHPL-49 given as a daily IV for 7 days to people who had a stroke. The goal was to see if it helps them recover better and is safe. 270 adults aged 18-80 with moderate to severe stroke took part. The main measure was how independent they we…
Phase: PHASE2 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
Herbal pill shows promise for neck nerve pain in new trial
Symptom relief CompletedThis study tested a Chinese herbal pill called Shenqi Sherong in 428 adults with mild to moderate cervical spondylotic myelopathy, a condition where the spinal cord in the neck is compressed. Participants took the pill or a placebo for up to 56 days. The main goal was to see if t…
Phase: PHASE3 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC